Louisiana State Employees Retirement System Halozyme Therapeutics, Inc. Transaction History
Louisiana State Employees Retirement System
- $5.06 Billion
- Q1 2024
A detailed history of Louisiana State Employees Retirement System transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 38,000 shares of HALO stock, worth $2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
38,000
Previous 37,100
2.43%
Holding current value
$2 Million
Previous $1.37 Million
12.69%
% of portfolio
0.03%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$959 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$686 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$341 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$216 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$199 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.32B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...